First Wave BioPharma Stock (NASDAQ: FWBI) stock price, news, charts, stock research, profile.
Open | $3.990 |
Close | $4.380 |
Volume / Avg. | 70.539K / 763.531K |
Day Range | 3.850 - 4.550 |
52 Wk Range | 2.750 - 72.998 |
Market Cap | $8.551M |
P/E Ratio | 0.004 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 0.7% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of First Wave BioPharma (NASDAQ: FWBI) through any online brokerage.
Other companies in First Wave BioPharma’s space includes: Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), BioRestorative Therapies (NASDAQ:BRTX), NexImmune (NASDAQ:NEXI) and Galera Therapeutics (NASDAQ:GRTX).
The latest price target for First Wave BioPharma (NASDAQ: FWBI) was reported by HC Wainwright & Co. on Monday, March 25, 2024. The analyst firm set a price target for 0.00 expecting FWBI to fall to within 12 months (a possible -100.00% downside). 10 analyst firms have reported ratings in the last year.
The stock price for First Wave BioPharma (NASDAQ: FWBI) is $4.33 last updated March 28, 2024 at 5:52 PM EDT.
There are no upcoming dividends for First Wave BioPharma.
First Wave BioPharma’s Q4 earnings are confirmed for Tuesday, April 9, 2024.
There is no upcoming split for First Wave BioPharma.
First Wave BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.